Aigen Investment Management, LP Adma Biologics, Inc. Transaction History
Aigen Investment Management, LP
- $533 Million
- Q4 2024
A detailed history of Aigen Investment Management, LP transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Aigen Investment Management, LP holds 29,513 shares of ADMA stock, worth $581,406. This represents 0.09% of its overall portfolio holdings.
Number of Shares
29,513
Previous 29,143
1.27%
Holding current value
$581,406
Previous $582,000
13.06%
% of portfolio
0.09%
Previous 0.12%
Shares
5 transactions
Others Institutions Holding ADMA
# of Institutions
338Shares Held
182MCall Options Held
1.72MPut Options Held
846K-
Black Rock Inc. New York, NY18.6MShares$367 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$359 Million0.01% of portfolio
-
State Street Corp Boston, MA14.9MShares$293 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA11.3MShares$223 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.53MShares$109 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.87B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...